Search - tctmd.com

Displaying 121 - 140 of 504

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Conference News ESC 2023

New Lancet Commission Takes Aim at Sudden Cardiac Deaths

Yael L. Maxwell

August 29, 2023

News Daily News

Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries

Caitlin E. Cox

August 24, 2023

News Daily News

Just a Few Thousand Daily Steps Can Rein in Mortality Risk: Meta-analysis

Caitlin E. Cox

August 11, 2023

News Daily News

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

Caitlin E. Cox

August 09, 2023

News Opinion CV Team Dispatch

August 2023 News Roundup

L.A. McKeown

August 01, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

A Focus on ‘Protective Foods’ Could Turn the Tide of CVD and Death

L.A. McKeown

July 07, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

Advertisement

October 2023 News Roundup

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

New Lancet Commission Takes Aim at Sudden Cardiac Deaths

Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries

Just a Few Thousand Daily Steps Can Rein in Mortality Risk: Meta-analysis

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

August 2023 News Roundup

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

A Focus on ‘Protective Foods’ Could Turn the Tide of CVD and Death

LDL Control Remains Poor in CAD Patients: NHANES

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content